Since our RAMS11 CRISPR KO lines had a significant decrease in cellular proliferation in vitro (Supplementary Fig. 2f, g), we evaluated tumor growth by injecting RAMS11 CRISPR KO cells into NOD/SCID immunocompromised mice. This evidence concerns the gene LINC01564 and neoplasm.